Breast cancer statistics and markers

Area of Science:

• Oncology
• Biomarker Research
• Cancer Diagnostics

Background:

• Breast cancer incidence and mortality are rising globally, particularly in Asia.
• Early diagnosis is crucial but remains a significant challenge.
• Current diagnostic markers have limitations in detecting early-stage breast cancer.

Purpose of the Study:

• To review existing breast cancer markers used in diagnosis.
• To highlight the limitations of current markers for early detection.
• To emphasize the need for improved early-stage breast cancer diagnostic markers.

Main Methods:

• Review of current literature on breast cancer diagnostic markers.
• Categorization of markers into tissue, genetic, and serum types.
• Analysis of the diagnostic capabilities of each marker category.

Main Results:

• Identified various tissue markers (e.g., hormone receptors, HER2, p53), genetic markers (e.g., BRCA1/2), and serum markers (e.g., CA 15.3, CEA).
• Concluded that none of the currently used markers can reliably diagnose breast cancer at its earliest stages.
• Highlighted the inadequacy of existing methods for early carcinogenesis detection.

Conclusions:

• There is a critical unmet need for novel biomarkers capable of early breast cancer detection.
• Developing new diagnostic tools is essential to improve patient survival rates.
• Further research is required to identify and validate markers for early-stage breast cancer diagnosis.